Feedback / Questions
PTX-252 - Pleco Therap, Hyloris Pharma
https://www.globenewswire.com/news-release/2024/01/16/2810252/0/en/Orphan-Drug-Designation-Granted-to-PTX-252-by-U-S-FDA-for-the-Treatment-of-Acute-Myeloid-Leukaemia-AML.html
Jan 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next